Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prima BioMed Ltd (NASDAQ:PBMD)

1.04
Delayed Data
As of May 27
 0.00 / 0.00%
Today’s Change
0.72
Today|||52-Week Range
3.27
-8.77%
Year-to-Date
Institutional investors control 0.33% of the outstanding shares in PBMD. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2015, these large investors purchased a net $147.2 thousand shares.
Other institutional0.32%
Mutual fund holders0.01%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/31/2016CITADEL ADVISORS LLC  Bought 67.3 Thousand shares of Prima BioMed Ltd
3/31/2016UBS SECURITIES LLC  Bought 5.3 Thousand shares of Prima BioMed Ltd
3/31/2016KCG AMERICAS LLC  Bought 4.8 Thousand shares of Prima BioMed Ltd

Top 10 Owners of Prima BioMed Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Citadel Advisors LLC0.10%67,34572,733+67,345--
Creative Planning, Inc.0.09%59,30064,044-700-1.17%
KCG Americas LLC0.07%48,53052,412+4,782+10.93%
BMO Capital Markets (Canada)0.03%20,00021,60000.00%
Wedbush Securities, Inc.0.03%20,00021,60000.00%
UBS Securities LLC0.01%5,2925,715+5,292--
Marketocracy Capital Management L...0.01%3,8004,104+3,800--
Merrill Lynch, Pierce, Fenner & S...0.00%50054000.00%
Tower Research Capital LLC0.00%00-356-100.00%
Citigroup Global Markets, Inc. (B...0.00%6267+62--

Top 10 Mutual Funds Holding Prima BioMed Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Marketocracy Masters 100 Fund0.01%3,8004,104+3,800--